|
Market Closed -
NSE India S.E.
05:41:03 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,450.00 INR | -0.60% |
|
-0.94% | -4.06% |
| 11/08 | Global drugmakers invest billions to boost US presence | RE |
| 28/07 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- CIPLA Stock
- Consensus Cipla Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
